NU141 Unit 9 Drug Class Comparison Example

Course	NU141 Pharmacology for Nursing
Unit	Unit 9
Paper type	Drug class comparison
Length	About 700 words, 5 pages double-spaced
Format	APA 7 student paper
School	Purdue University Global
Program	BSN (prelicensure)
Updated	October 2026

Free sample paper for NU141 Unit 9

Four Insulins on One Page: A Drug Class Comparison of Rapid-Acting Lispro, Short-Acting Regular, Intermediate NPH and Long-Acting Glargine, Reading Each Difference in Onset, Peak and Duration as a Nursing Consequence for a Composite Patient

[Student Name]

Purdue University Global

NU141: Pharmacology for Nursing

Unit 9 Drug Class Comparison

[Instructor Name]

[Date]

The patient is composite; onset, peak and duration are typical approximate ranges and bracketed, and product labeling and facility protocols govern.

What this part is doingEvery pharmacologic difference in the comparison is turned into something the nurse does, which is the point of comparing the types.

Why Compare Insulins

Insulin replaces or supplements the body's own hormone, which moves glucose into cells. Products differ mainly in how fast they start working, when their effect is strongest and how long it lasts, and those timing differences decide when each is given, when hypoglycemia is most likely and how it is matched to meals (Burchum & Rosenthal, 2022). Current diabetes standards describe a basal-bolus approach in which a long-acting insulin covers the body's background needs and a rapid-acting insulin covers meals (American Diabetes Association Professional Practice Committee, 2024).

The Comparison

1. Lispro, rapid-acting. Onset about [15] minutes; peak about [1] to [2] hours; duration about [3] to [5] hours. Clear. Given within [15] minutes before a meal or right after eating. Nursing consequence: the meal tray must be present before the dose; a delayed tray after lispro is a common cause of hypoglycemia within the hour.

2. Regular, short-acting. Onset about [30] minutes; peak about [2] to [4] hours; duration about [6] to [8] hours. Clear. Given about [30] minutes before meals; the only type commonly given IV. Nursing consequence: timing relative to meals is less flexible than lispro, and its longer tail can cause a low before the next meal.

3. NPH, intermediate-acting. Onset about [1] to [2] hours; peak about [4] to [12] hours; duration about [12] to [18] hours. Cloudy suspension. Must be gently rolled to mix before drawing up. Nursing consequence: the broad peak means hypoglycemia can occur hours after the dose, including overnight if given in the evening; when mixed with regular in one syringe, regular is drawn up first, clear before cloudy.

4. Glargine, long-acting. Onset about [1] to [2] hours; no pronounced peak; duration about [24] hours. Clear. Given once daily at the same time. Must not be mixed with any other insulin. Nursing consequence: because it looks like regular and lispro, it is easy to confuse; it is usually continued even when the patient is not eating, as ordered, since it covers background needs.

Clear is not a description of safety; three of the four look identical in the vial, and only labels separate a mealtime dose from a twenty-four-hour one.

Reading the Differences for One Patient

Patient K, a composite 60-year-old man with type 2 diabetes, is on glargine [20] units at [9 p.m.] and lispro by a carbohydrate scale with meals. At breakfast his tray is delayed [40] minutes. The nurse holds the lispro until the tray arrives and he has started eating, because its onset of fifteen minutes would leave him with insulin acting and no food. He is told he will be NPO after midnight for a procedure; the nurse confirms with the prescriber whether his glargine should be given in full or reduced, rather than holding it automatically, because stopping basal insulin can lead to high glucose.

What this part is doingThe patient example shows two decisions, holding mealtime insulin and clarifying basal insulin, each following from the timing differences.

Hypoglycemia Timing

The time of greatest risk follows the peak: about one to two hours after lispro, two to four hours after regular, four to twelve hours after NPH, and lower but present at any time with glargine. Point-of-care glucose checks follow the ordered schedule, and nurses know the signs of hypoglycemia, shakiness, sweating, confusion and a fast heart rate, and the facility's treatment protocol.

High-Alert Status

Insulin is a high-alert medication because errors can cause serious harm. Common safeguards include independent double checks for certain doses, never using the abbreviation "U" for units, and keeping pens to a single patient (Institute for Safe Medication Practices, 2024).

Summary

The four insulins differ less in what they do than in when they do it, and nearly every nursing action around insulin, timing doses to meals, watching for lows, mixing correctly and avoiding confusion, follows from those timing differences.

References

American Diabetes Association Professional Practice Committee. (2024). 9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes 2024. Diabetes Care, 47(Suppl. 1), S158-S178. https://doi.org/10.2337/dc24-S009

Burchum, J. R., & Rosenthal, L. D. (2022). Lehne's pharmacology for nursing care (11th ed.). Elsevier.

Institute for Safe Medication Practices. (2024). ISMP list of high-alert medications in acute care settings. Institute for Safe Medication Practices.

The Purdue Global NU141 Unit 9 instructions

Unit 9 usually asks you to compare the members of one drug class in a single structured format, most often insulins. Prompts commonly want each product's key properties side by side, the clinical meaning of each difference and nursing implications, sometimes applied to a patient. Two to four pages, organized as a table or parallel list, is common. Faculty look for accurate onset, peak and duration ranges, appearance and mixing rules, and for every property translated into a nursing action. Applying the comparison to a patient shows that the differences matter at the bedside. Safety issues specific to the class, such as look-alike vials and high-alert status, are often expected in the answer.

How the NU 141 Unit 9 example is put together

The comparison opens by explaining why insulin products differ mainly in timing and introducing the basal-bolus approach from current diabetes standards. Four numbered entries follow, one per insulin, each with onset, peak, duration, appearance, timing and a nursing consequence. The highlighted line warns that three of the four look identical. A composite patient on glargine and lispro shows two decisions: holding lispro until a late breakfast tray arrives and clarifying basal insulin before a procedure rather than holding it. A section maps hypoglycemia risk to each peak. High-alert safeguards, from double checks to never abbreviating units, and a one-sentence summary close it. Each entry uses the same order of properties, so the four can be read across.

NU141 Unit 9 rubric: what earns full points

Drug class comparisons in NU 141 tend to be graded on accuracy, completeness, translation into nursing actions, and safety awareness. Accuracy earns credit for correct onset, peak, duration and handling rules, stated as approximate ranges. Completeness rewards covering every product and property the prompt names in a consistent, parallel format. Translation is weighted heavily: each difference should lead to something the nurse does, such as timing a dose to a meal tray. Safety awareness points go to class-specific risks, such as confusing clear insulins and mixing rules. Applying the comparison to a patient, with sources in APA 7, usually lifts the paper above a reference table. A comparison that a new nurse could keep in a pocket and use tells a grader the translation worked.

NU141 Unit 9 help: mistakes that cost points

Comparisons often reproduce a reference table of onset, peak and duration without saying what any of it means for care. Another frequent error is giving exact times as if they were fixed, when they vary by patient and product. Some papers forget mixing rules or say glargine may be mixed with other insulins. Many leave out the risk of confusing clear vials. Present the products in parallel, give ranges rather than single numbers, turn each difference into an action, include appearance and mixing rules, apply the comparison to a patient's day, and name the safeguards that protect against insulin errors. End with the one difference you think matters most and say why.

Get an NU141 Unit 9 example written to your instructions

Which insulins, or which endocrine class, does your Unit 9 prompt ask you to compare? Include that with the rubric and any required table format. The comparison comes back organized by question, with sources for every time value, in 24-48h, and the first custom sample is free. Oral agents such as metformin and the sulfonylureas work in the same format. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.

More NU141 papers and BSN samples

NU141 Unit 9 questions, answered

Where can I find a free NU141 Unit 9 sample paper?

You can read the full NU141 Unit 9 comparison of lispro, regular, NPH and glargine here, with timing, appearance, mixing rules, nursing consequences, a patient example and safety measures, citing three sources. We can compare another drug class for you.

When should lispro be given in NU141 Unit 9?

Within about 15 minutes before a meal or right after eating, and only when the meal tray is present, because its fast onset can cause hypoglycemia if food is delayed.

Which insulin is cloudy and how is it mixed?

NPH is a cloudy suspension that must be gently rolled before drawing up. When mixed with regular in one syringe, regular is drawn up first, clear before cloudy.

Can glargine be mixed with other insulins?

No. Glargine must not be mixed with any other insulin. It is given once daily at the same time and covers background needs.

When is hypoglycemia most likely with each insulin?

Around its peak: about one to two hours after lispro, two to four after regular, four to twelve after NPH, and with lower but steady risk at any time with glargine.